ALGS – aligos therapeutics, inc. - common stock (US:NASDAQ)
Stock Stats
News
Aligos Therapeutics (ALGS) was upgraded by Jefferies Financial Group Inc. to "strong-buy".
Aligos Therapeutics (ALGS) is now covered by Westpark Capital. They set a "buy" rating and a $48.00 price target on the stock.
Aligos Therapeutics (ALGS) was upgraded by Jefferies Financial Group Inc. to "strong-buy".
Aligos Therapeutics (ALGS) is now covered by Jefferies Financial Group Inc.. They set a "buy" rating and a $48.00 price target on the stock.
Aligos Therapeutics (ALGS) had its "buy" rating reaffirmed by HC Wainwright. They now have a $50.00 price target on the stock.
Form 4 Aligos Therapeutics, For: Mar 09 Filed by: Symons Julian A.
Form 4 Aligos Therapeutics, For: Mar 09 Filed by: Aneja Nikhil
Form 4 Aligos Therapeutics, For: Mar 09 Filed by: BLATT LAWRENCE
Form 4 Aligos Therapeutics, For: Mar 09 Filed by: Calhoun Lesley Ann
Form S-8 Aligos Therapeutics,
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.